1-20 of 24
Christie M. Ballantyne
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Proteomic Predictors of Incident Diabetes: Results From the Atherosclerosis Risk in Communities (ARIC) Study

Free
Mary R. Rooney, Jingsha Chen, Justin B. Echouffo-Tcheugui, Keenan A. Walker, Pascal Schlosser, Aditya Surapaneni, Olive Tang, Jinyu Chen, Christie M. Ballantyne, Eric Boerwinkle, Chiadi E. Ndumele, Ryan T. Demmer, James S. Pankow, Pamela L. Lutsey, Lynne E. Wagenknecht, Yujian Liang, Xueling Sim, Rob van Dam, E. Shyong Tai, Morgan E. Grams, Elizabeth Selvin, Josef Coresh
Journal: Diabetes Care
Diabetes Care 2023;46(4):733–741
https://doi.org/10.2337/dc22-1830
Published: 27 January 2023
View articletitled, Proteomic Predictors of Incident Diabetes: Results From the Atherosclerosis Risk in Communities (ARIC) Study
Open the PDF for Proteomic Predictors of Incident Diabetes: Results From the Atherosclerosis Risk in Communities (ARIC) Study in another window
Journal Articles

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs

Free
Dhruv Mahtta, David J. Ramsey, Michelle T. Lee, Liang Chen, Mahmoud Al Rifai, Julia M. Akeroyd, Elizabeth M. Vaughan, Michael E. Matheny, Karla Rodrigues do Espirito Santo, Sankar D. Navaneethan, Carl J. Lavie, Yochai Birnbaum, Christie M. Ballantyne, Laura A. Petersen, Salim S. Virani
Journal: Diabetes Care
Diabetes Care 2022;45(2):372–380
https://doi.org/10.2337/dc21-1815
Published: 17 January 2022
View articletitled, Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs
Open the PDF for Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs in another window
Journal Articles

Racial and Geographic Disparities in Internet Use in the U.S. Among Patients With Hypertension or Diabetes: Implications for Telehealth in the Era of COVID-19

Free
Vardhmaan Jain, Mahmoud Al Rifai, Michelle T. Lee, Ankur Kalra, Laura A. Petersen, Elizabeth M. Vaughan, Nathan D. Wong, Christie M. Ballantyne, Salim S. Virani
Journal: Diabetes Care
Diabetes Care 2021;44(1):e15–e17
https://doi.org/10.2337/dc20-2016
Published: 02 November 2020
View articletitled, Racial and Geographic Disparities in Internet Use in the U.S. Among Patients With Hypertension or Diabetes: Implications for Telehealth in the Era of COVID-19
Open the PDF for Racial and Geographic Disparities in Internet Use in the U.S. Among Patients With Hypertension or Diabetes: Implications for Telehealth in the Era of COVID-19 in another window
Journal Articles

High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes

Free
Olive Tang, Kunihiro Matsushita, Josef Coresh, Chiadi Ndumele, John W. McEvoy, A. Richey Sharrett, Ron Hoogeveen, Christie M. Ballantyne, Elizabeth Selvin
Journal: Diabetes Care
Diabetes Care 2020;43(10):e144–e146
https://doi.org/10.2337/dc20-1312
Published: 11 August 2020
View articletitled, High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes
Open the PDF for High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes in another window
Journal Articles

Facility-Level Variation in Cardiac Stress Test Use Among Patients With Diabetes: Findings From the Veterans Affairs National Database

Free
Dhruv Mahtta, Sarah T. Ahmed, Nishant R. Shah, David J. Ramsey, Julia M. Akeroyd, Khurram Nasir, Ihab R. Hamzeh, Islam Y. Elgendy, Stephen W. Waldo, Mouaz H. Al-Mallah, Hani Jneid, Christie M. Ballantyne, Laura A. Petersen, Salim S. Virani
Journal: Diabetes Care
Diabetes Care 2020;43(5):e58–e60
https://doi.org/10.2337/dc19-2160
Published: 11 March 2020
View articletitled, Facility-Level Variation in Cardiac Stress Test Use Among Patients With Diabetes: Findings From the Veterans Affairs National Database
Open the PDF for Facility-Level Variation in Cardiac Stress Test Use Among Patients With Diabetes: Findings From the Veterans Affairs National Database in another window
Journal Articles

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease

Free
Gregory G. Schwartz, Lawrence A. Leiter, Christie M. Ballantyne, Philip J. Barter, Donald M. Black, David Kallend, Fouzia Laghrissi-Thode, Eran Leitersdorf, John J.V. McMurray, Stephen J. Nicholls, Anders G. Olsson, David Preiss, Prediman K. Shah, Jean-Claude Tardif, John Kittelson
Journal: Diabetes Care
Diabetes Care 2020;43(5):1077–1084
https://doi.org/10.2337/dc19-2204
Published: 06 March 2020
View articletitled, Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
Open the PDF for Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease in another window
Includes: Supplementary data
Journal Articles

Mortality Implications of Prediabetes and Diabetes in Older Adults

Free
Olive Tang, Kunihiro Matsushita, Josef Coresh, A. Richey Sharrett, John W. McEvoy, B. Gwen Windham, Christie M. Ballantyne, Elizabeth Selvin
Journal: Diabetes Care
Diabetes Care 2020;43(2):382–388
https://doi.org/10.2337/dc19-1221
Published: 27 November 2019
View articletitled, Mortality Implications of Prediabetes and Diabetes in Older Adults
Open the PDF for Mortality Implications of Prediabetes and Diabetes in Older Adults in another window
Includes: Supplementary data
Journal Articles

High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study

Free
Seamus P. Whelton, John W. McEvoy, Mariana Lazo, Josef Coresh, Christie M. Ballantyne, Elizabeth Selvin
Journal: Diabetes Care
Diabetes Care 2017;40(2):261–269
https://doi.org/10.2337/dc16-1541
Published: 15 November 2016
View articletitled, High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study
Open the PDF for High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study in another window
Includes: Supplementary data
Journal Articles

Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

Open Access
Mauro Gori, Deepak K. Gupta, Brian Claggett, Elizabeth Selvin, Aaron R. Folsom, Kunihiro Matsushita, Natalie A. Bello, Susan Cheng, Amil Shah, Hicham Skali, Orly Vardeny, Hanyu Ni, Christie M. Ballantyne, Brad C. Astor, Barbara E. Klein, David Aguilar, Scott D. Solomon
Journal: Diabetes Care
Diabetes Care 2016;39(5):677–685
https://doi.org/10.2337/dc15-1760
Published: 06 January 2016
View articletitled, Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Open the PDF for Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study in another window
Includes: Supplementary data
Journal Articles

Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD

Free
L. Maria Belalcazar, Wei Lang, Steven M. Haffner, Dawn C. Schwenke, Andrea Kriska, Ashok Balasubramanyam, Ron C. Hoogeveen, F. Xavier Pi-Sunyer, Russell P. Tracy, Christie M. Ballantyne, the Look AHEAD (Action for Health in Diabetes) Research Group
Journal: Diabetes Care
Diabetes Care 2015;38(8):1544–1550
https://doi.org/10.2337/dc14-2775
Published: 13 May 2015
View articletitled, Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD
Open the PDF for Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD in another window
Includes: Supplementary data
Journal Articles

High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN

Free
Brian Stegman, Rishi Puri, Leslie Cho, Mingyuan Shao, Christie M. Ballantyne, Phillip J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Yu Kataoka, Steven E. Nissen, Stephen J. Nicholls
Journal: Diabetes Care
Diabetes Care 2014;37(11):3114–3120
https://doi.org/10.2337/dc14-1121
Published: 10 October 2014
View articletitled, High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN
Open the PDF for High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN in another window
Includes: Supplementary data
Journal Articles

Novel Risk Factors and the Prediction of Type 2 Diabetes in the Atherosclerosis Risk in Communities (ARIC) Study

Open Access
L.A. Raynor, PHD, James S. Pankow, PHD, Bruce B. Duncan, MD, Maria I. Schmidt, MD, Ron C. Hoogeveen, PHD, Mark A. Pereira, PHD, J. Hunter Young, MD, Christie M. Ballantyne, MD
Journal: Diabetes Care
Diabetes Care 2013;36(1):70–76
https://doi.org/10.2337/dc12-0609
Published: 11 December 2012
View articletitled, Novel Risk Factors and the Prediction of Type 2 Diabetes in the Atherosclerosis Risk in Communities (ARIC) Study
Open the PDF for Novel Risk Factors and the Prediction of Type 2 Diabetes in the Atherosclerosis Risk in Communities (ARIC) Study in another window
Includes: Supplementary data
Journal Articles

Racial Differences in Association of Elevated Interleukin-18 Levels With Type 2 Diabetes: The Atherosclerosis Risk in Communities Study

Open Access
Smita I. Negi, MD, James S. Pankow, PHD, Karl Fernstrom, BS, Ron C. Hoogeveen, PHD, Na Zhu, PHD, David Couper, PHD, Maria I. Schmidt, MD, Bruce B. Duncan, MD, Christie M. Ballantyne, MD
Journal: Diabetes Care
Diabetes Care 2012;35(7):1513–1518
https://doi.org/10.2337/dc11-1957
Published: 12 June 2012
View articletitled, Racial Differences in Association of Elevated Interleukin-18 Levels With Type 2 Diabetes: The Atherosclerosis Risk in Communities Study
Open the PDF for Racial Differences in Association of Elevated Interleukin-18 Levels With Type 2 Diabetes: The Atherosclerosis Risk in Communities Study in another window
Includes: Supplementary data
Journal Articles

Nontraditional Markers of Glycemia: Associations with microvascular conditions

Open Access
Elizabeth Selvin, PHD, Lesley M.A. Francis, MSC, Christie M. Ballantyne, MD, Ron C. Hoogeveen, PHD, Josef Coresh, MD, Frederick L. Brancati, MD, Michael W. Steffes, MD
Journal: Diabetes Care
Diabetes Care 2011;34(4):960–967
https://doi.org/10.2337/dc10-1945
Published: 21 March 2011
View articletitled, Nontraditional Markers of Glycemia: Associations with microvascular conditions
Open the PDF for Nontraditional Markers of Glycemia: Associations with microvascular conditions in another window
Includes: Supplementary data
Journal Articles

A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change: From the Look AHEAD (Action for Health in Diabetes) study

Open Access
L. Maria Belalcazar, MD, David M. Reboussin, PHD, Steven M. Haffner, MD, Ron C. Hoogeveen, PHD, Andrea M. Kriska, PHD, Dawn C. Schwenke, PHD, Russell P. Tracy, PHD, F. Xavier Pi-Sunyer, MD, Christie M. Ballantyne, MD, for the Look AHEAD Research Group
Journal: Diabetes Care
Diabetes Care 2010;33(11):2297–2303
https://doi.org/10.2337/dc10-0728
Published: 03 August 2010
View articletitled, A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change: From the Look AHEAD (Action for Health in Diabetes) study
Open the PDF for A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change: From the Look AHEAD (Action for Health in Diabetes) study in another window
Includes: Supplementary data
Journal Articles

Marine ω-3 Fatty Acid Intake: Associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study

Open Access
L. Maria Belalcazar, MD, David M. Reboussin, PHD, Steven M. Haffner, MD, Rebecca S. Reeves, DRPH, Dawn C. Schwenke, PHD, Ron C. Hoogeveen, PHD, F. Xavier Pi-Sunyer, MD, Christie M. Ballantyne, MD, for the Look AHEAD (Action for Health in Diabetes) Obesity, Inflammation, and Thrombosis Research Group
Journal: Diabetes Care
Diabetes Care 2010;33(1):197–199
https://doi.org/10.2337/dc09-1235
Published: 19 October 2009
View articletitled, Marine ω-3 Fatty Acid Intake: Associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study
Open the PDF for Marine ω-3 Fatty Acid Intake: Associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study in another window
Includes: Supplementary data
Journal Articles

Statin-Induced Diabetes: Will It Change Clinical Practice?

Open Access
L. Maria Belalcazar, MD, Vasudevan A. Raghavan, MBBS, MD, MRCP, Christie M. Ballantyne, MD
Journal: Diabetes Care
Diabetes Care 2009;32(10):1941–1943
https://doi.org/10.2337/dc09-1277
Published: 01 October 2009
View articletitled, Statin-Induced Diabetes: Will It Change Clinical Practice?
Open the PDF for Statin-Induced Diabetes: Will It Change Clinical Practice? in another window
Journal Articles

Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance: The Atherosclerosis Risk in Communities Study

Free
James S. Pankow, PHD, David K. Kwan, MPH, Bruce B. Duncan, MD, PHD, Maria I. Schmidt, MD, PHD, David J. Couper, PHD, Sherita Golden, MD, Christie M. Ballantyne, MD
Journal: Diabetes Care
Diabetes Care 2007;30(2):325–331
https://doi.org/10.2337/dc06-1457
Published: 01 February 2007
View articletitled, Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance: The Atherosclerosis Risk in Communities Study
Open the PDF for Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance: The Atherosclerosis Risk in Communities Study in another window
Journal Articles

Identifying Individuals at High Risk for Diabetes: The Atherosclerosis Risk in Communities study

Free
Maria Inês Schmidt, MD, PHD, Bruce B. Duncan, MD, PHD, Heejung Bang, PHD, James S. Pankow, PHD, Christie M. Ballantyne, MD, Sherita H. Golden, MD, MHS, Aaron R. Folsom, MD, Lloyd E. Chambless, PHD, for the Atherosclerosis Risk in Communities Investigators
Journal: Diabetes Care
Diabetes Care 2005;28(8):2013–2018
https://doi.org/10.2337/diacare.28.8.2013
Published: 01 August 2005
View articletitled, Identifying Individuals at High Risk for Diabetes: The Atherosclerosis Risk in Communities study
Open the PDF for Identifying Individuals at High Risk for Diabetes: The Atherosclerosis Risk in Communities study in another window
Journal Articles

The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study

Free
Ann Marie McNeill, PHD, Wayne D. Rosamond, PHD, Cynthia J. Girman, DRPH, Sherita Hill Golden, MD, MHS, Maria I. Schmidt, MD, Honey E. East, MD, Christie M. Ballantyne, MD, Gerardo Heiss, MD, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(2):385–390
https://doi.org/10.2337/diacare.28.2.385
Published: 01 February 2005
View articletitled, The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study
Open the PDF for The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study in another window